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Abstract
Background: Airborne particulate matter, from cooking oil, smoking, engine exhaust and other
sources, is associated with the development of atherosclerosis and myocardial infarction. In order
to explore the cellular and molecular events following exposure of rats to lard oil smoke, we
measured the generation of reactive oxygen species (ROS), substance P, cellular adhesion
molecules, and thrombosis in relation to inhibitors of substance P, the NK-1 receptor, and
antioxidants.
Methods: Rats were exposed to oil smoke for 120 min with or without 20 min pretreatment with
lovastatin (substance P scavenger), L733060 (NK-1 receptor antagonist), vitamin E (antioxidant) or
catechins (antioxidant). The levels of substance P and ROS were measured. Histological studies
observed ROS damage in the form of HEL adducts. The prothrombotic effects of oil smoke
exposure were measured by experimental induction of thrombosis in vivo.
Results: Oil smoke exposure significantly increased substance P levels, ROS levels, ROS damage
(HEL adduct levels), and the size of experimentally induced thrombi. The pretreatments reduced
all of these effects of oil smoke exposure; at many time points the reductions were statistically
significant.
Conclusion: We established a connection between oil smoke exposure and thrombosis which
involves substance P and its receptor, the NK-1 receptor, and ROS. This study helps establish a
mechanistic explanation of how airborne particulate matter can increase the risk of cardiovascular
illness.
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Background
A variety of chemical reactions occur while high tempera-
ture (150–400°C) cooking oils (e.g. sunflower oil, soy-
bean oil, or lard) are being heated before food is added to
the pan [1-3]. Several volatile chemicals such as formalde-
hyde, benzene, acetaldehyde and acrolein are present in
fumes generated from frying and are thought to be associ-
ated with contents of cooking oil and foods [1-3]. Partic-
ulate air pollution is also generated and is associated with
cardiovascular disease and myocardial infarction [4].
Indoor inhalation of atmospheric particulate matter
(APM) from cooking has been associated with respiratory
and cardiovascular diseases [5,6]. APM is as an important
risk, particularly for cooks, in areas where pan-fry cooking
is popular.
Inhalation of the APM from cooking has been suggested
to impact on the non-adrenergic and non-cholinergic
(NANC) nervous system, leading to changes in breathing
pattern, smooth muscle, or blood vessels in order to regu-
late visceral motility and blood flow [7]. APM from cook-
ing may affect the cardiovascular system through
inflammatory mediators produced in the lungs and
released into the circulation [7]. NANC stimulation and
overflow of inflammatory mediators from the lungs into
blood may constitute an alternative and a complementary
explanation for the acute cardiovascular events after expo-
sure to APM [7].
Substance P (SP) is an NANC signaling molecule that
induces a range of neuroimmunogenic effects on target
smooth muscle or parasympathetic ganglia cells express-
ing neurokinin-1 or neurokinin-2 receptors (NK-1R, NK-
2R) [8-12]. Neurogenic airway inflammation comprises
bronchoconstriction, microvascular plasma leakage, neu-
trophil recruitment and inflammatory mediator synthesis.
SP-mediates neutrophil adhesion to bronchial epithelial
and endothelial cells and further augments the proinflam-
matory response and oxidative stress via production of
intercellular adhesion molecule-1 (ICAM-1), chemok-
ines/cytokines, arachidonic acid products, and reactive
oxygenated species (ROS)/nitric oxide (NO) derivatives
such as hydroxyl radicals and superoxides [10,12,13].
Recently, we have shown that oil smoke exposure (OSE)
causes a time-related release of SP in bronchoalveolar lav-
age fluid (BALF) 0–8 h after OSE in rats [7]. Substantial
elevations in tumour necrosis factor-α (TNF-α) and IL-1
beta gene expression, superoxide anion levels, epithelial
cell necrosis and alveolar hypoventilation after OSE were
also noted [7].
SP and NK1R have also recently been recognized to be
involved in thrombosis [14-18]. SP can increase the
chance of thrombosis. And, thrombosis can lead to myo-
cardial infarctions and strokes [15]. Thus, SP signaling
may explain APM exposure can lead to increased inci-
dences of thrombosis and myocardial infarctions [4].
The precise role that SP plays in mediating neurogenic
inflammation through interaction with NK-1R and conse-
quent ROS and ICAM-1 formation following OSE was
clarified in our previous study [7]. The goal of this study
was (1) to evaluate the oxidative stress enhanced throm-
bus and its relationship to the pulmonary inflammation
accompanying exposure following OSE and (2) to investi-
gate the mechanism of this phenomenon.
Methods
Animals
Male Sprague-Dawley rats (12 to 14 weeks-old, weighing
200 to 250 g) were housed at the Experimental Animal
Center, I-Shou University, in a temperature controlled
environment with light from 0700 to 1800 h. Animal care
and experimental protocols were in accordance with
guidelines of the National Science Council of the Republic
of China (NSC1997). All experiments were approved by
the Institutional Animal Care and Use Committee
(IACUC) of I-Shou University, Kaohsiung, Taiwan
(IACUC Protocol no. AUP-96-55-001 and Approval no.
IACUC-ISU-96014).
Rats were anesthetized with 1.2 g/kg subcutaneous ure-
thane (Sigma, St. Louis, MO, USA). Then, the trachea was
cannulated caudal to the larynx (PE-200), and femoral
vein catheters (PE-50, Clay-Adams, Parsippany, NJ, USA)
were inserted to facilitate blood sampling and drug
administration. Blood vessel patency was maintained by
intravenous saline infusion at 1.2 ml/min via an infusion
pump (CH-4103; Infors, Bottmingen, Switzerland). Fem-
oral arterial catheters were placed for measurement of
arterial blood pressure (ABP). This was recorded using a
polygraph (ML845 PowerLab 4/25 T system, ADInstru-
ments, Sydney, Australia).
Pretreatment with substance P scavenger, neurokinin-1 
receptor antagonist, or antioxidants
On the experimental day, groups of rats were pretreated
with either: L733060, an NK-1 receptor antagonist
(Sigma); lovastatin, a cholesterol or substance P scavenger
(Sigma); vitamin E, an H2O2 scavenger (Sigma); or cate-
chins, which are O2 
- and H2O2 scavengers. We adminis-
tered: 1 μg/kg L733060 dissolved in 10% dimethyl
sulphoxide (DMSO) in 0.9% saline; 4 mg/kg lovastatin
dissolved in 50% DMSO in PBS; 2.5 mg/kg vitamin E (1
mg/mL in 0.9% saline); or 2.5 mg/kg catechins (consist-
ing of 328 mg/g epigallocatechin gallate, 132 mg/g epi-
catechin, 108 mg/g epigallocatechin, 104 mg/g
galloctechin, and 44 mg/g catechin; Numen Biotech, Tai-
pei, Taiwan) in 0.9% saline. All drugs were administered
as a bolus via the femoral catheter. Atropine (1 mg/mL/Journal of Biomedical Science 2009, 16:58 http://www.jbiomedsci.com/content/16/1/58
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kg) was given 20 min before OSE to inhibit cholinergic
innervation of the airway nervous system.
Compulsory oil smoke exposure (OSE)
Compulsory oil smoke exposure followed our previously
published procedure [7] with modifications. Briefly, in
our custom-built apparatus, oil was heated to produce
smoke, the smoke was passed into an artificial respirator
machine, and cooled smoke was forced through tracheot-
omies into the lungs of anesthetized rats. To produce the
smoke, 500 mL of lard was placed in a ceramic crucible
and burned in the stainless steel smoke chamber. This
thermal furnace system produced a consistent high tem-
perature of 350 ± 6°C. The effluent oil smoke generated
was vacuum transferred through an inverted funnel can-
opy into the sealed chamber of the artificial respirator.
The smoke was cooled in the artificial respirator device,
and the mean smoke temperature for all exposures was
32.6 ± 1.7°C. The artificial respirator was attached to the
trachea of urethane-anesthetized, cannulated rats, and
then cooled oil smoke was artificially respirated through
the rats at a continuous flow (dynamic) rate of 2 L/min for
120 min (compulsory oil smoke exposure; OSE). Control
rats were artificially respirated with ambient room air
only.
Rats that survived the OSE procedure were sacrificed
immediately and up to 24 h following OSE to assess lung
injury (specific details of this follow). A further subset of
(non-pretreated) rats was exposed to OSE for 0 and 120
min and killed thereafter between 0 and 24 h for assess-
ment of SP levels in plasma and ROS levels in blood.
Measurement of substance P
SP levels in plasma supernatant were quantified using a
commercial enzyme immunoassay kit (Cayman Chemi-
cal, Ann Arbor, MI, USA) following the manufacturer's
instructions. The concentration of SP in plasma was
expressed in pg/mL.
Measurement of reactive oxygen species
The effect of treatments on plasma ROS levels was meas-
ured using the lucigenin-enhanced chemiluminescence
method. Lucigenin reacts almost exclusively with ROS
under optimal laboratory conditions and is commonly
used to increase the sensitivity of cellular chemilumines-
cence assays [19]. For this measurement, 0.1 mL of PBS
(pH 7.4) was added to each 0.2 mL arterial blood sample.
The chemiluminescence of the sample was then measured
in the dark chamber of the chemiluminescence analyzing
system. After a 100-s background level luminescence
determination, 0.5 mL of 0.1 mM lucigenin solution in
PBS (pH 7.4) was added to the sample and chemilumines-
cence was monitored continuously for an additional 600
s. The total amount of chemiluminescence was calculated
by integrating of the area under the 600 s chemilumines-
cence curve and subtracting the background luminescence
level. The assay was performed in duplicate for each sam-
ple, and the results expressed as chemiluminescence
counts/10 s.
Measurement of damage caused by reactive oxygen 
species
Hexanoyl-lysine (HEL), a biomarker for ROS damage, is
generated when ROS oxidize lipids and those lipid
hydroperoxides modify proteins at lysine residues; HEL is
detectable by an anti-HEL antibody [20].
To determine if HEL had been generated at various times
following OSE stimulation, lungs were removed and fixed
by perfusing 10% buffered formalin through the trachea
at a pressure of 30 cm H2O for 24 h. The lungs were then
dehydrated through a series of ethanol solutions, cleared
with methylsalicylate, and embedded in paraffin. Sections
of the lung tissue (5 μm) were mounted on glass slides
and stained with hematoxylin and eosin for examination
by light microscopy. For immunohistochemical analysis,
the sections were first treated with blocking buffer for 15
min to block nonspecific background binding. Primary
rabbit-antiserum (anti-VCAM-1 or anti-HEL, 1:1000) was
then applied overnight at 4°C. The anti-VCAM-1 was
obtained from R&D system and the monoclonal anti-HEL
antibody (Kato, et al., 2000) was from JaICA (Fukuroi
City, Japan). After rinses in PBS, sections were treated with
the Zymed Histostain kit (Zymed Laboratories, South San
Francisco, CA, USA). This included secondary bioti-
nylated goat anti-rabbit serum followed by horseradish
peroxidase-conjugated streptavidin and subsequent
development in a diaminobenzidine-substrate solution,
yielding a permanent reddish brown reaction product. All
slides were permanently coverslipped with crystal-mount.
The presence of HEL was also determined by immunos-
taining western blots of proteins from the right lung fol-
lowing OSE. For protein analysis, lung samples were
homogenized with a pre-chilled mortar and pestle in
extraction buffer (10 mM Tris-HCl [pH 7.6], 140 mM
NaCl, 1 mM phenylmethylsulfonyl fluoride, 1% NP-40,
0.5% deoxycholate, 2% β-mercaptoethanol, 10 μg/mL
pepstatin A, and 10 μg/mL aprotinin). The homogenate
was maintained at 4°C for 30 min, and then centrifuged
at 12,000 g for 12 min at 4°C to collect the supernatant.
Protein concentrations were determined by BioRad pro-
tein assay (BioRad Laboratories, Hercules, CA, USA). The
protein samples (30 μg total protein per lane) were sepa-
rated on 12.5% SDS-polyacrylamide gel electrophoresis
(PAGE) separation gels in the absence of urea, stained
with Coomassie brilliant blue, and transferred to nitrocel-
lulose filters. Immunoreactive bands were detected by
incubating with primary antibodies for HEL for approxi-Journal of Biomedical Science 2009, 16:58 http://www.jbiomedsci.com/content/16/1/58
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mately 4 h, followed by an alkaline phosphatase-conju-
gated secondary antibody for 1 h, and finally developed
with nitroblue tetrazolium and a 5-bromo-4-chloro-3-
indolyl phosphate toluidine salt (Roche Diagnostic, Man-
nheim, Germany) stock solution for 30 min at room tem-
perature.
Measurement of thrombosis
To measure the effects of OSE on thrombosis formation
we followed the method of Nemmar et al. [18]. Briefly, an
anesthetized rat was intravenously infused with a solution
of Rose Bengal and a section of the femoral vein was sur-
gically exposed. This vein was then exposed to green light
(540 nm) for 2 min, which causes the Rose Bengal to pro-
duce ROS that cause an endothelial lesion and then
thrombosis.
The kinetics of thrombus generation were monitored
using a microscope video camera. MetaMorph imaging
software was used for image processing on a preset scale
of arbitrary units ranging from 0 to 4,095. All images were
processed to the same scale, and the average light intensity
of each field was obtained. The size of the thrombus was
expressed in arbitrary units (A.U.) as the total area under
the curve of light intensity plotted against time.
Statistical methods
Normally distributed continuous variables were com-
pared by one-way analysis of variance (ANOVA). When a
significant difference between groups was apparent, mul-
tiple comparisons of means were performed using
Scheffe's test. Data are presented as means ± SE. All statis-
tical assessments were two-sided and evaluated at the 0.05
level of significant difference. Statistical analyses were per-
formed using SPSS 15.0 statistics software (SPSS Inc, Chi-
cago, IL).
Results
Effects of oil smoke exposure
Compared to control rats exposed to ambient air, the rats
given OSE showed an increasing plasma SP level until 8 h
following compulsory OSE, then gradually reducing
(Table 1). There was also a concomitant increase in ROS
in the plasma from the OSE group between 0 and 8 h after
OSE, then reducing to a plateau (Table 1). There were sig-
nificant differences in substance P and plasma ROS
between OSE and control groups at all time points follow-
ing OSE (P < 0.05). Histologically, oil smoke exposure
caused microscopic hemorrhaging and the sloughing of
cells around the bronchi of rat lung (Fig. 1C); at the same
time, the amount of inflammatory cells observed in the
lung tissues (Fig. 1B, D, E, F) were increased compared to
mnoraml rat lungs (Fig. 1A).
Effects of treatments before oil smoke exposure
We studied the effect of OSE on the levels of plasma SP by
using enzyme-linked immunoassay and on the levels of
plasma ROS by using ROS-induced chemiluminescence.
Table 1 shows the SP and ROS levels in plasma following
120 min of OSE and for the 4 pretreatment groups. There
were highly increased levels of SP and ROS after OSE
alone. The SP and ROS levels were lower when 1 μg/kg
L733060, 4 mg/kg lovastatin, 2.5 mg/kg vitamin E, or 2.5
mg/kg catechins pretreatment was provided before OSE.
Compared to the control, at each time point there were
statistically significant differences from control (all P = <
0.001) in both SP and ROS levels after OSE. Compared to
the SP levels after OSE, all the pretreatments we used
reduced the effect of OSE on SP; however, only the effect
of pretreatment with 1 μg/kg L733060 was statistically sig-
nificant. After pretreatment with 1 μg/kg L733060, OSE
induced 58% less SP at 1 h, and 47% less SP at 8 h. Like-
Table 1: Amount of substance P and reactive oxygen species (ROS) in plasma following oil smoke exposure (OSE)
Control (n = 8) OSE (n = 8) L733060+OSE 
(n = 8)
Lovastatin+OSE 
(n = 8)
Vitamin E+OSE 
(n = 8)
Catechins+OSE 
(n = 8)
P-value^
Substance-P (pg/mL)
1 h after OSE 1.83 ± 0.44 54.71 ± 9.40a 23.00 ± 4.58b 48.29 ± 9.44a 27.57 ± 4.63 24.71 ± 4.83 < 0.001*
8 h after OSE 1.82 ± 0.50 72.93 ± 7.31a 38.99 ± 6.21a, b 57.13 ± 7.94a 51.38 ± 6.74a, † 45.50 ± 5.42a, † < 0.001*
24 h after 
OSE
1.96 ± 0.48 61.44 ± 6.69a 35.86 ± 4.61a 58.25 ± 6.20a 52.63 ± 6.82a, † 46.50 ± 5.72a, † < 0.001*
Plasma ROS (counts/10 s)
1 h after OSE 103.86 ± 8.08 966.29 ± 107.17a 642.43 ± 96.50a 730.89 ± 115.32a 597.14 ± 77.70a 522.57 ± 87.07 < 0.001*
8 h after OSE 91.63 ± 6.78 2103.13 ± 
204.06a, †
954.75 ± 68.99a, b 1502.25 ± 
129.07a, †
1169.38 ± 
145.79a, b, †
922.25 ± 112.51a, 
b, †
< 0.001*
24 h after 
OSE
108.43 ± 8.76 1806.16 ± 
111.21a, †
1270.14 ± 
127.84a, †
1325.29 ± 
133.98a, †
1193.43 ± 
192.99a, †
1185.71 ± 
109.51a, †
< 0.001*
^ P-values based on ANOVA test. Pair-wise multiple comparisons between groups determined using Scheffe's test.
* Statistical significance, P < 0.05
a Significantly different from control group at the respective time interval
bSignificantly different from OSE group at the respective time interval
†Significantly different from treatment results at 1 h after OSEJournal of Biomedical Science 2009, 16:58 http://www.jbiomedsci.com/content/16/1/58
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wise, compared to the ROS levels after OSE, all the pre-
treatments we used reduced the effect of OSE on ROS.
However, only at the peak effect (the 8 h time point) did
pretreatment with either 1 μg/kg L733060, 2.5 mg/kg vita-
min E, or 2.5 mg/kg catechins statistically significantly
reduce the effect of OSE on ROS. OSE induced 55% less
ROS at 8 h when pretreated with 1 μg/kg L733060, 44%
less ROS with 2.5 mg/kg vitamin E, and 56% less with 2.5
mg/kg catechins.
ROS lung damage indicated by HEL levels
Because we found that OSE increased ROS in BALF [7] and
in plasma, we wanted to see if this was causing damage to
the lung tissues. HEL is a marker for ROS damage; ROS
oxidize lipids, and the resulting lipid peroxides modify
proteins, creating HEL residues as a product. We immuno-
histochemically stained for HEL in lung tissues, and
found that OSE produced HEL in and around the capillar-
ies and lymphatic-like channels (Fig. 2D, E). After OSE,
we also observed strong expression of VCAM-1, a mole-
cule that recruits immune cells and is implicated in the
generation of atherosclerosis (Fig. 2A, B). We have previ-
ously shown that OSE causes SP to interact with the NK-1
receptor and increase ROS [7]. Therefore we disrupted this
process with 1 μg/kg of the NK-1 receptor inhibitor
L733060, and we found that both less VCAM-1 and less
HEL were induced after OSE (Fig. 2C, F).
In addition to our qualitative microscopic observations,
we investigated the effect of ROS after OSE by immunob-
lotting for HEL in western blots of total lung proteins. The
western blots were probed with anti-β-actin as a baseline
control and then with monoclonal anti-HEL antibody
(Fig. 3A). In the western blot, the monoclonal antibody
detected a 150 kDa band representing HEL-modified
VLDL [21]. Using the 150 kDa HEL band and the 42 kDa
actin band, the HEL/β-actin ratio was calculated from
densitometry of the western blots as a quantitative meas-
ure of oxidative damage (Fig. 3B). In control rats that did
not receive OSE, the HEL/β-actin ratio was 0.134. Expos-
ing rats to oil smoke for 60 min increased the HEL to an
HEL/β-actin ratio of 1.56, and to 2.49 at 120 min OSE.
Pretreatment significantly decreased the HEL/β-actin ratio
following 120 min OSE: 0.54, 1 μg/kg L733060; 0.65, 4
mg/kg lovastatin; 0.52, 2.5 mg/kg vitamin E; 0.43, 2.5 mg/
kg catechins.
Effect of OSE on thrombosis
Rats were given 120 min OSE and then used in the exper-
imental thrombosis test at different times after the OSE
Representative histopathological slides from lung tissue following oil smoke exposure (OSE) Figure 1
Representative histopathological slides from lung tissue following oil smoke exposure (OSE). (A) The trachea 
shows normal structure without inflammation. (B) Peripheral lung tissue shows interstitial pneumonitis with infiltration of lym-
phplasmacytic cells after oil smoke exposure. (C) Peribronchiolar hemorrhage and sloughing of bronchiolar epithelium. (D) 
Heavy infiltration of lymphocytes and some histiocytes and neutrophils in peribronchiolar areas. (E) The lung tissue shows mild 
lymphoplasmacytic infiltration in the submucosal area. (F) Neutrophilic infiltration in the alveolar space and interstitium.Journal of Biomedical Science 2009, 16:58 http://www.jbiomedsci.com/content/16/1/58
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treatment. We wanted to see if the increases in ROS that
we observed after OSE correlated with a change in throm-
bosis. OSE induced a significant increase in the cumula-
tive mass of thrombus generated in vivo at 0 (350%), 4
(354%), 8 (667%), 12 (583%) and 24 h (401%) com-
pared with the thrombi induced in control rats at each
time point (all P < 0.05). The peak of thrombus formation
was at 8 and 12 h after OSE. These were significantly dif-
ferent than thrombus formation at 0 h after OSE (P <
0.05), corresponding with the statistically significant
peaks of SP and ROS at 8 h following OSE (Table 1).
Thrombus formation was also studied in rats pretreated
with inhibitors and antioxidants before 120 min OSE
(Table 2). All pretreatments reduced the size of thrombus
induced. Notably, 4 mg/kg lovastatin was least effective at
reducing SP and ROS levels (Table 1) but was most effec-
tive at reducing thrombus formation (Table 2). At 1 h after
OSE, the rats pretreated with 4 mg/kg lovastatin had no
significant difference from control rats in the size of exper-
imental thrombus formed. The pretreatments were all less
effective at reducing thrombus formation at later time
points. At 24 h after OSE thrombus formation in the pre-
treated rats was not significantly different than rats receiv-
ing OSE alone.
Table 3 shows the amount of platelets, RBCs, WBCs and
fibrinogen after 120 min OSE. After 120 min OSE, rats
receiving OSE alone showed significantly different
increases from control rats in platelets, RBCs, WBCs and
fibrinogen. All pretreatments reduced the platelet, RBC,
WBC and fibrinogen levels (Table 3). Pretreatment with 4
mg/kg lovastatin was highly effective at increasing WBC
count from control rats. Moreover, WBC in the rats pre-
treated with 2.5 mg/kg catechins were significantly differ-
ent than WBC in rats receiving OSE alone And, fibrinogen
in rats pretreated with 4 mg/kg lovastatin was significantly
different than WBC in rats receiving OSE alone.
Discussion
This study explored the effects of APM on rats by exposing
them for a short period of time to lard oil smoke, a type of
APM exposure that might be normally encountered by
people, especially when cooking. By pretreating the rats
Immunohistochemical evaluation of oil smoke exposure (OSE) on lung tissues Figure 2
Immunohistochemical evaluation of oil smoke exposure (OSE) on lung tissues. Lung tissues were paraffin-embed-
ded, sectioned, and stained brown with antibodies to VCAM-1 (A-C) or HEL (D-F). All images are × 200. (A) Endothelial cells 
in the capillaries of control rats (0 min OSE) did not stain for VCAM-1. (B) The endothelial cells of medium-sized vessels 
stained strongly for VCAM-1 after 120 min OSE. (C) When pretreated with the NK-1 receptor antagonist L733060, the 
endothelial cells in capillaries and medium- to large-sized vessels stained weakly for VCAM-1 after 120 min OSE. (D) Endothe-
lial cells in the capillaries of control rats (0 min OSE) did not stain for HEL. (E) Endothelial cells in capillaries and lymphatic-like 
channels are positive for HEL after 120 min OSE. (F) When pretreated with L733060, endothelial cells in capillaries are positive 
and pneumocytes are negative for HEL after 120 min OSE.Journal of Biomedical Science 2009, 16:58 http://www.jbiomedsci.com/content/16/1/58
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with single doses of various inhibitors and antioxidants,
we explored the mechanisms involved in the physiologi-
cal response to oil smoke exposure. Because we only used
single doses of each pretreatment (rather than generating
dose-response curves), no conclusions can be drawn
about the relative efficacy of each type of pretreatment.
This study is limited to general conclusions about the
mechanisms underlying the physiological responses to oil
smoke APM.
Smoking (both active and passive) increases the cardio-
vascular risk of atherosclerosis and thrombosis. Vascular
inflammation and oxidative stress caused by inhalation of
cigarette smoke are thought to be initiating events that
lead to these two outcomes. The reactive oxygen species
generated during oxidative stress oxidize low density lipo-
protein, a reaction that makes LDL more easily taken up
by macrophages, which are then deposited as foam cells
in atherosclerotic plaques in the arteries [22]. If the
plaques rupture, the tissue factor on the macrophages in
the plaques comes in contact with clotting factors in the
blood and thrombosis results. There is also a body of evi-
dence suggesting that smoking up-regulates the coagula-
tion system, thus making it easier for any pro-coagulatory
stimulus to cause thrombus formation.
Many lines of evidence attribute the initiation of athero-
sclerosis to a complex series of events and circulating fac-
tors acting on immune cells and the smooth muscle and
endothelial cells making up the blood vessels. Here and in
our previous paper we demonstrated that insult to the
lungs by oil smoke was followed by an increase in SP lev-
els in bronchoalveolar lavage fluid (BALF) [7] and
plasma. The SP may have been released from sensory
nerve endings in response to the oil smoke particles [23].
After OSE, ROS levels also rose along with the rise in SP
levels in BALF [7] and in plasma. OSE causes interstitial
pneumonitis in rat lung tissue, thickening of the alveolar-
capillary membrane, and a large increase in inflammatory
cells and dying epithelial cells [7]. Inhibiting SP, inhibit-
ing the NK-1 receptor, or using antioxidants reduced the
Measurement of oxidative damage following oil smoke expo- sure (OSE) Figure 3
Measurement of oxidative damage following oil 
smoke exposure (OSE). (A) Western blots were probed 
with a monoclonal antibody to HEL, an early and stable 
marker for lipid peroxidation derived protein oxidation. (B) 
The 150 kDa band from the HEL immunoblot was compared 
to the 42 kDa actin band by densitometry analysis. Mean and 
range of 8 replicate experiments are presented. The lanes 
contained protein samples from rat lungs exposed to 0, 60 or 
120 min OSE, as well as samples from rats pretreated with 
L733060 (L), lovastatin (Lov), vitamin E (VitE), or catechins 
(C). * Indicates a significant difference from control rats with 
0 min OSE. ** Indicates a significant difference from rats 
exposed to 120 min oil smoke without pretreatment; – 
Without drug pretreatment.
Table 2: Amount of thrombosis induced in rats 1, 8, or 24 h following oil smoke exposure (OSE)
Control (n = 8) OSE (n = 8) L733060+OSE 
(n = 8)
Lovastatin+OSE 
(n = 8)
Vitamin E+OSE 
(n = 8)
Catechins+OSE 
(n = 8)
P-value^
Thrombus size (A.U.)
1 h after OSE 10659 ± 695 45562 ± 3470a 29778 ± 3366a, b 22855 ± 2525b 31712 ± 3751a 26903 ± 2380 a, b < 0.001*
8 h after OSE 10509 ± 783 65794 ± 4327a, † 38742 ± 4999a, b 27660 ± 2052a, b 35589 ± 2579a, b 36541 ± 3359a, b < 0.001*
24 h after OSE 10458 ± 709 52416 ± 3191a 41574 ± 4772a 36955 ± 4246a, † 49068 ± 4881a, † 38707 ± 5560a < 0.001*
^ P-values based on ANOVA test. Pair-wise multiple comparisons between groups determined using Scheffe's test.
* Statistical significance, P < 0.05
a Significantly different from control group at the respective time interval
bSignificantly different from OSE group at the respective time interval
†Significantly different from treatment results at 1 h after OSEJournal of Biomedical Science 2009, 16:58 http://www.jbiomedsci.com/content/16/1/58
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effects of OSE. This suggests that OSE stimulates SP release
which, acting via the NK-1 receptor, attracts leukocytes
which generate ROS.
Signs of leukocyte recruitment after OSE include histolog-
ical observation of increased neutrophils, monocytes and
leukocytes in lung tissue [7], as well as increased expres-
sion of the endothelial surface proteins intercellular adhe-
sion molecule-1(ICAM-1) [7] and VCAM-1, which recruit
inflammatory cells. Inflammatory recruitment is a step in
the progression of early atherosclerosis. Increases in mol-
ecules such as ICAM-1 and VCAM-1 may also be impor-
tant with regard to smooth muscle cells [24]. Both the
smooth muscle cells and endothelial cells lining vessels
can absorb damaged lipids and become foam cells [25].
The ICAM-1 and VCAM-1 molecules stabilize these cells
against apoptosis which helps form the initial accumula-
tion of cells of an atherosclerotic plaque [24]. Likewise,
lovastatin can reduce oxidative damage to mouse lungs
during reperfusion injury and reverse upregulation of
VCAM-1 [26], and catechins can reduce SP-mediated ROS
and ICAM-1 expression in irritated bladders [13].
Atherosclerotic plaques stain strongly for HEL [27], and
we found that OSE stimulated the formation of HEL in
lung tissues, an effect that was reversible by inhibiting the
SP pathway with the NK-1 receptor antagonist, lovastatin
or antioxidants. Other studies have come to similar con-
clusions about the connection between smoke particle
inhalation and lung tissue damage. Yasuda et al. exposed
mice to diesel exhaust particles (DEP) and argued that the
particles generated ROS; they observed a number of DNA,
protein and lipid damage products (including HEL) that
are attributable to ROS because they could be prevented
by antioxidants [28]. They also observed an increase in
VCAM-1 and ICAM-1. Their results agree with ours, but
we demonstrate further that the mechanism involved is
not the direct generation of ROS by combustion particles,
but the generation of ROS following SP/NK-1R signaling
and an inflammatory response. Arguing against the
importance of the type of particles is an experiment in
which hamsters inhaled 400-nm polystyrene particles;
these hamsters also developed inflammation, released
histamine and had enhanced thrombosis [17].
In hamsters, diesel exhaust particles cause platelet activa-
tion and enhance experimental thrombosis [18]. The DEP
exposure increases platelet activity, and increases the his-
tamine and the number of neutrophils in the hamster
BALF; inhibiting the histamine H1 receptor reduces the
neutrophilia but does not affect the prothrombotic effects
[18]. In conjunction with our results from oil smoke expo-
sure in rats, we can propose that the DEP exposure in
hamsters caused release of SP, which was directly involved
in the prothrombotic effect. The increase in neutrophils,
and possibly other inflammatory cells, may involve a
pathway instigated by SP that is dependent upon hista-
mine.
Acute exposure to APM, such as exposure to cooking oil
smoke, can lead to increased numbers of activated white
bloods cells, which can lead to increased NADPH oxidase
activity and add to the risk of coagulation/thrombosis,
development of atherosclerosis, and atherosclerotic
plaque vulnerability [4]. We found increased white blood
cells following acute oil smoke exposure, as well as
increased platelets and fibrinogen (Table 3). The
increased platelets and fibrinogen could be responsible
for increased thrombosis [4]. Jones et al. [15] show that
platelets express NK-1R and that substance P promotes
thrombosis. Inhibition of NK-1R reversed this effect [15].
These results provide a mechanism to explain why throm-
bosis was affected by OSE in our experiments. Jones et al.
suggest that NK-1R antagonists may be useful antithrom-
botic drugs.
Because substance P has many functions, it remains a
question what the beneficial function of SP is in response
to combustion particles. It is possible that substance P is
only incidentally promoting platelet activation and ROS
Table 3: Amount of platelet, RBC, WBC and fibrinogen after 120 min oil smoke exposure (OSE)
Control (n = 8) OSE (n = 8) L733060+OSE 
(n = 8)
Lovastatin+OSE 
(n = 8)
Vitamin E+OSE 
(n = 8)
Catechins+OSE 
(n = 8)
P-value^
Platelet (×103/
μL)
103.88 ± 18.30 410.63 ± 45.30a 223.13 ± 41.11 188.25 ± 20.51 268.00 ± 73.58 257.00 ± 47.70 0.001*
RBC (×106/μL) 1.54 ± 0.31 5.03 ± 0.75a 3.24 ± 0.47 3.11 ± 0.49 2.91 ± 0.50 2.68 ± 0.35 0.001*
WBC (×103/μL) 1056 ± 105 5722 ± 693a 3403 ± 465 4127 ± 617a 3240 ± 605 3088 ± 409b < 0.001*
Fibrinogen 
(mg/dl)
48.88 ± 9.00 340.00 ± 49.89a 213.00 ± 38.08 157.88 ± 26.90b 176.75 ± 34.33 224.13 ± 45.09 < 0.001*
^ P-values based on ANOVA test. Pair-wise multiple comparisons between groups determined using Scheffe's test.
* Statistical significance, P < 0.05
a Significantly different from control group
bSignificantly different from OSE groupJournal of Biomedical Science 2009, 16:58 http://www.jbiomedsci.com/content/16/1/58
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generation in addition to some beneficial effect. Further
exploration of the detailed mechanisms following smoke
particle exposure are needed to determine which inhibi-
tors (such as SP inhibitors, NK-1R inhibitors, or antioxi-
dants) are appropriate to use to combat the unwanted side
effects without preventing potential protective functions
of SP stimulation. Smoke inhalation is connected with
carcinogenesis, and the SP-induced attraction of immune
cells may help collect and destroy the particulate matter.
But, the attracted immune cells generate ROS, which are
damaging, and the increased SP may also activate platelets
and promote foam cell accumulation, predisposing to
atherosclerosis and myocardial infarction.
The temptation to use NK-1R inhibitors, such as L733060,
as antithrombotics [14] should be approached with cau-
tion because they can also cross the blood-brain-barrier
and affect the neurological functions of SP [29-31]. It
might be worthwhile to investigate alternate targets in the
pathway, such as DPPIV, which interacts with the SP/NK-
1R inflammatory pathway in allergic rhinitis [32].
Conclusion
Exposure to APM is associated with increased risk of
atherosclerosis and myocardial infarction. This study adds
to the literature on the mechanism connecting APM to
these health risks. OSE stimulated an increase in SP in the
plasma, which in turn seems to have recruited inflamma-
tory cells that generate ROS, as evidenced by increases in
endothelial attachment molecules (VCAM-1). We meas-
ured increases in HEL, showing that the ROS damaged lip-
ids and proteins after OSE. HEL and other oxidative lipid
damage can promote lipid accumulation by macrophages
and smooth muscle cells to form foam cells, which collect
into early atherosclerotic plaques. Thus, oil smoke expo-
sure had two main outcomes: 1) ROS Damage (due to SP
recruiting inflammatory cells, and the inflammatory cells
generating ROS, leading to immediate lipid damage, and
then foam cells, and then long-term accumulation of
atherosclerotic plaque); and 2) thrombosis (due to SP
activating platelets via the NK-1 receptor). These two sep-
arate pathways could converge again when thrombosis
causes the rupture of existing atherosclerotic plaques and
causes myocardial infarction.
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